.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Salivary gland cancers represent a rare and complex group of neoplasms. Among these, salivary duct adenocarcinoma (SDC) is particularly aggressive. Clinicians often face challenges because these tumors exhibit squamous differentiation and resist standard therapies. Consequently, researchers are exploring molecular targets like p63 to improve salivary duct adenocarcinoma therapy. Recent studies have focused on the relationship between p63 expression and tight junction proteins, which are essential for maintaining cell polarity and barrier function.
Researchers recently investigated the role of deltaNp63 in SDC using p63-negative PGC2E cells. By overexpressing deltaNp63, they observed a significant increase in nuclear p63 expression. Simultaneously, this process reduced the levels of cingulin (CGN), a critical tight junction protein, at the cell membrane. This shift significantly altered the tumor's behavior. Specifically, the overexpression of deltaNp63 disrupted epithelial polarity and weakened permeability barriers. Furthermore, it promoted rapid cell proliferation and migration while enhancing cellular metabolism.
The study also examined how specific inhibitors affect SDC cells. Scientists found that histone deacetylase (HDAC) and nuclear factor kappa B (NF-kB) inhibitors could induce apoptosis in these malignant cells. Additionally, antibodies targeting tumor necrosis factor-α (TNF-α) and the lipolysis-stimulated lipoprotein receptor (LSR) showed potential. However, the presence of p63 often prevented this induced cell death. These findings highlight that p63 acts as a major driver of malignancy. Therefore, targeting p63 pathways could be a cornerstone of future salivary duct adenocarcinoma therapy protocols.
p63 plays a vital role in cell proliferation, migration, and apoptosis. In salivary gland tumors, its overexpression often correlates with squamous differentiation and increased malignancy, making it a potential therapeutic target.
Tight junctions maintain the polarity and permeability of epithelial cells. When proteins like cingulin are reduced, the resulting loss of polarity can facilitate cancer cell migration and metabolic shifts that favor tumor growth.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional consultation. Refer to the latest local and national guidelines for clinical practice.
References
Oyanagi M et al. P63 and Tight Junctions Targeted for Therapy in Human Salivary Duct Adenocarcinoma Cells. J Histochem Cytochem. 2026 May 19. doi: 10.1369/00221554261435677. PMID: 42153350.
Kojima T, et al. Inhibition of HDAC and Signal Transduction Pathways Induces Tight Junctions and Promotes Differentiation in p63-Positive Salivary Duct Adenocarcinoma. Cancers (Basel). 2022;14(11):2618.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Scientists identify p63 and tight junction proteins as key drivers of salivary duct adenocarcinoma malignancy, opening doors for novel targeted therapies....
3 months ago
A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
